Advertisement

Latest News

AI Assessments, Robotics Perform to Rheumatologist Levels in Joint Assessment

4 hours ago

Data from 2 studies presented at ACR 2024 demonstrate the potential of AI to improve access to quality rheumatological assessments.

Phase 2 Data Support Muvalaplin for Lowering Lp(a), with Stephen Nicholls, MBBS, PhD

4 hours ago

Stephen Nicholls, MBBS, PhD, provides additional insight into KRAKEN trial data and the potential of muvalaplin.

Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial

6 hours ago

Marianna Fontana, MD, PhD discusses Phase 1 interim results on the CRISPR-based gene-editing therapy, nex-z, for ATTR-CM.

Peanut-Sensitized Infants with Eczema Already Co-Sensitized to Tree Nuts

7 hours ago

This analysis evaluated the frequency of peanut-sensitized infants and toddlers being sensitized to other types of nuts.

Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD

9 hours ago

Stephen J. Nicholls, MD, PhD discusses the robust efficacy and tolerability of zerlasiran for Lp(a) lowering, paving the way for Phase 3 development.

Advertisement
Advertisement